Infusion Pumps Market Growth Driven by Rising Need for Chronic Disease Management
According to our new research study on “Infusion Pumps Market Forecast to 2034 – Global Analysis – by Product, Customer, and End User,” the Infusion Pumps market size is expected to grow from US$ 11.46 billion in 2025 to US$ 18.65 billion by 2034, with a CAGR of 5.6% during 2026–2034. The major factors that are driving the infusion pumps market growth are the rising incidence of chronic diseases, the growing geriatric population, and technological innovations. The rise of smart and AI-driven infusion is projected to bring new infusion pumps market trends in the coming years.
Infusion pumps provide accurate medication delivery, which is essential for treating chronic diseases that require continuous treatment. The WHO reported that noncommunicable diseases (NCDs)—including cardiovascular diseases, cancers, chronic respiratory diseases, and diabetes—caused 43 million deaths in 2021, representing 75% of non-pandemic deaths and 82% of all early deaths in developing nations. Cardiovascular disease remains the leading cause of death, claiming 19.8 million lives in 2022 (32% of all deaths), with 612 million cases globally and projections indicating a 90% rise by 2050. The International Diabetes Federation (IDF) Diabetes Atlas reported that 589 million adults had diabetes in 2024, but 252 million of them remained undiagnosed, with the condition projected to affect 853 million people by 2050.
Infusion Pumps Market, by Region, 2025 (%)
Infusion Pumps Market Growth, Trends & Demand by 2034
Download Free Sample
Infusion Pumps Market Size and Forecast (2021 - 2034), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (IV infusion Pumps, Syringe Infusion Pumps, Volumetric infusion Pumps, Ambulatory Pumps, Patient-Controlled Analgesia (PCA) Pumps, Enteric Feeding Pumps, Disposable Elastomeric Pumps, and Other Products), Customer (Small Hospitals & Nursing Home, Standalone Hospitals, Tertiary Care Hospitals, and Hospital Chain), End User (Anaesthesiologists, Critical Care Specialists, and Other End Users), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
Infusion Pumps Market Growth, Trends & Demand by 2034
Download Free SampleInfusion Pumps Market Size and Forecast (2021 - 2034), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (IV infusion Pumps, Syringe Infusion Pumps, Volumetric infusion Pumps, Ambulatory Pumps, Patient-Controlled Analgesia (PCA) Pumps, Enteric Feeding Pumps, Disposable Elastomeric Pumps, and Other Products), Customer (Small Hospitals & Nursing Home, Standalone Hospitals, Tertiary Care Hospitals, and Hospital Chain), End User (Anaesthesiologists, Critical Care Specialists, and Other End Users), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
Source: The Insight Partners Analysis
FDA-approved insulin pumps deliver continuous subcutaneous insulin infusion, helping patients control blood sugar levels and reduce health complications. Chemotherapy pumps used in oncology deliver exact drug quantities, which provides effective treatment results while minimizing adverse reactions. Infusion pumps function as vital instruments for chronic disease treatment because they increase treatment precision and enable patients to receive care at home. They also help decrease the need for hospital re-admissions, which benefits patient outcomes.
Infusion Pumps Market Analysis Based on Segmental Evaluation:
Based on product, the market is segmented into IV infusion pumps, syringe infusion pumps, volumetric infusion pumps, ambulatory pumps, patient-controlled analgesia (PCA) pumps, enteric feeding pumps, disposable elastomeric pumps, and other products. In 2025, the IV infusion pumps segment held a significant infusion pumps market share. These infusion pumps are employed for the accurate administration of fluids, drugs, blood products, and nutrients intravenously, making them an essential part of critical care, surgical emergency, and general hospital settings.
Their programmable flow rates, safety functions, and connectivity with hospital information systems improve the accuracy of medications and patient safety, minimizing the risk of errors involved in manual IV administration. Advances in technology—such as smart infusion pumps with dose-error reduction systems, wireless connectivity, and alarms—further increase their usage in hospitals. Moreover, the growing number of chronic diseases, surgeries, and critical care requirements also ensures a steady demand for IV infusion pumps. The infusion pumps market also has a large customer base, including large hospitals, small clinics, and home healthcare, making it highly scalable. This ensures that the IV infusion pumps market continues to hold a dominant market share in 2025.
The scope of the infusion pumps market report includes an assessment of the market performance in North America, Europe, Asia Pacific, South and Central America, and Middle East and Africa. In terms of revenue, North America dominated the infusion pumps market share in 2025. The market in the US is fueled by the growing number of chronic illnesses and the aging population. Sedentary lifestyles have led to a rise in cardiovascular disease, diabetes, and obesity. According to the CDC (2023), 40.1 million adults in the US had diabetes, including 11 million with undiagnosed diabetes. Each year, there were 1.4 million new cases, and 7 million adults required daily insulin treatment (Yale).
Market expansion is fueled by FDA approvals and major market players. For instance, SQ Innovation received FDA clearance for Lasix ONYU—a subcutaneous infusion system for heart failure edema—expanding ambulatory therapy options. These factors collectively drive strong demand for infusion pumps in the US.
B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Co., Cardinal Health Inc., GE HealthCare Technologies Inc., Fresenius Kabi AG, Terumo Corp, ICU Medical Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., and BPL Medical Technologies Pvt Ltd are among the leading companies profiled in the infusion pumps market report.
Based on product, the infusion pumps market is segmented into IV infusion pumps, syringe infusion pumps, volumetric infusion pumps, ambulatory pumps, patient-controlled analgesia (PCA) pumps, enteric feeding pumps, disposable elastomeric pumps, and other products. Based on customer, the market is segmented into small hospitals and nursing home, standalone hospitals, tertiary care hospitals, and hospital chain. By end user, the market is categorized into anaesthesiologists, critical care specialists, and other end users.
In terms of geography, the market is divided into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), South and Central America (Brazil, Argentina, and the Rest of South and Central America), and Middle East and Africa (Saudi Arabia, the UAE, South Africa, and the Rest of Middle East and Africa).
Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com